124 related articles for article (PubMed ID: 12235553)
1. [Induction of remission with infliximab in therapy-refractory Wegener's granulomatosis - Follow-up of six patients].
Lamprecht P; Arbach O; Voswinkel J; Lilienthal T; Nölle B; Heller M; Gause A; Gross WL
Dtsch Med Wochenschr; 2002 Sep; 127(37):1876-80. PubMed ID: 12235553
[TBL] [Abstract][Full Text] [Related]
2. [Infliximab in the treatment of Wegener's granulomatosis: case report].
Svozílková P; Ríhová E; Brichová M; Diblík P; Kuthan P; Poch T
Cesk Slov Oftalmol; 2006 Jul; 62(4):280-6. PubMed ID: 16895062
[TBL] [Abstract][Full Text] [Related]
3. Etanercept plus standard therapy for Wegener's granulomatosis.
Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
N Engl J Med; 2005 Jan; 352(4):351-61. PubMed ID: 15673801
[TBL] [Abstract][Full Text] [Related]
4. [How long should cyclophosphamide therapy of Wegener's granulomatosis continue?].
Reinhold-Keller E
Dtsch Med Wochenschr; 2002 Sep; 127(37):1909-10. PubMed ID: 12226791
[No Abstract] [Full Text] [Related]
5. [Treatment of ANCA-associated vascularitides].
Guillevin L; Pagnoux C
Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
[TBL] [Abstract][Full Text] [Related]
6. Wegener granulomatosis (granulomatosis with polyangiitis): evolving concepts in treatment.
Lynch JP; Tazelaar H
Semin Respir Crit Care Med; 2011 Jun; 32(3):274-97. PubMed ID: 21674414
[TBL] [Abstract][Full Text] [Related]
7. [Wegener's granulomatosis and microscopic polyangiitis].
Pagnoux C
Rev Prat; 2008 Mar; 58(5):522-32. PubMed ID: 18524109
[TBL] [Abstract][Full Text] [Related]
8. Control of a relapse and induction of long-term remission of Wegener's granulomatosis by cyclosporine.
Ghez D; Westeel PF; Henry I; Pruna A; Fournier A; Lassoued K
Am J Kidney Dis; 2002 Aug; 40(2):E6. PubMed ID: 12148127
[TBL] [Abstract][Full Text] [Related]
9. Treatment strategies and outcome of induction-refractory Wegener's granulomatosis or microscopic polyangiitis: analysis of 32 patients with first-line induction-refractory disease in the WEGENT trial.
Seror R; Pagnoux C; Ruivard M; Landru I; Wahl D; Rivière S; Aussant S; Mahr A; Cohen P; Mouthon L; Guillevin L;
Ann Rheum Dis; 2010 Dec; 69(12):2125-30. PubMed ID: 20643762
[TBL] [Abstract][Full Text] [Related]
10. B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study.
Martinez Del Pero M; Chaudhry A; Jones RB; Sivasothy P; Jani P; Jayne D
Clin Otolaryngol; 2009 Aug; 34(4):328-35. PubMed ID: 19673980
[TBL] [Abstract][Full Text] [Related]
11. Wegener's granulomatosis.
Lamprecht P; Gross WL
Herz; 2004 Feb; 29(1):47-56. PubMed ID: 14968341
[TBL] [Abstract][Full Text] [Related]
12. Rituximab for remission induction in a patient with relapsing necrotizing scleritis associated with limited Wegener's granulomatosis.
Onal S; Kazokoglu H; Koc A; Yavuz S
Ocul Immunol Inflamm; 2008; 16(5):230-2. PubMed ID: 19065418
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].
Tervaert JW; Stegeman CA
Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2265-7. PubMed ID: 14655291
[TBL] [Abstract][Full Text] [Related]
14. Refractory Wegener's granulomatosis responds to tumor necrosis factor blockade.
Kleinert J; Lorenz M; Köstler W; Hörl W; Sunder-Plassmann G; Soleiman A
Wien Klin Wochenschr; 2004 May; 116(9-10):334-8. PubMed ID: 15237661
[TBL] [Abstract][Full Text] [Related]
15. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
Pagnoux C; Mahr A; Hamidou MA; Boffa JJ; Ruivard M; Ducroix JP; Kyndt X; Lifermann F; Papo T; Lambert M; Le Noach J; Khellaf M; Merrien D; Puéchal X; Vinzio S; Cohen P; Mouthon L; Cordier JF; Guillevin L;
N Engl J Med; 2008 Dec; 359(26):2790-803. PubMed ID: 19109574
[TBL] [Abstract][Full Text] [Related]
16. Plasma exchange for induction and cyclosporine A for maintenance of remission in Wegener's granulomatosis--a clinical randomized controlled trial.
Szpirt WM; Heaf JG; Petersen J
Nephrol Dial Transplant; 2011 Jan; 26(1):206-13. PubMed ID: 20577017
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations.
Seo P; Specks U; Keogh KA
J Rheumatol; 2008 Oct; 35(10):2017-23. PubMed ID: 18688911
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of Wegener's granulomatosis].
Riccieri V; Valesini G
Reumatismo; 2004; 56(2):69-76. PubMed ID: 15309213
[TBL] [Abstract][Full Text] [Related]
19. Clinical review: Vasculitis on the intensive care unit -- part 2: treatment and prognosis.
Semple D; Keogh J; Forni L; Venn R
Crit Care; 2005 Apr; 9(2):193-7. PubMed ID: 15774077
[TBL] [Abstract][Full Text] [Related]
20. Effect of rituximab on refractory Wegener granulomatosis with predominant granulomatous disease.
Sánchez-Cano D; Callejas-Rubio JL; Ortego-Centeno N
J Clin Rheumatol; 2008 Apr; 14(2):92-3. PubMed ID: 18391678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
